TMCI (Treace Medical Concepts) Marketable Securities: $33.0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TMCI Treace Medical Concepts Inc TMCI
68 GF Score
Price $4.79
GF Value $6.35
Valuation Modestly Undervalued
! 6 Warning Signs
View Full Analysis

What is Treace Medical Concepts Marketable Securities?

Treace Medical Concepts TMCI +6.21% 68 Marketable Securities is $33.0 Mil as of Jun. 2026. GuruFocus rates TMCI with a GF Score™ of 68/100 and a GF Value™ of $6.35 (Modestly Undervalued). The stock has 6 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Treace Medical Concepts's Marketable Securities for the quarter that ended in Jun. 2026 was $33.0 Mil.

Treace Medical Concepts's annual Marketable Securities declined from Dec. 2023 ($110.2 Mil) to Dec. 2024 ($64.3 Mil) and declined from Dec. 2024 ($64.3 Mil) to Dec. 2025 ($37.7 Mil).

Treace Medical Concepts  (NAS:TMCI) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Treace Medical Concepts Marketable Securities Related Terms

Treace Medical Concepts Marketable Securities Historical Data

* Premium members only.

The historical data trend for Treace Medical Concepts's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Treace Medical Concepts Marketable Securities Chart

Treace Medical Concepts Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial 0.00 61.78 110.22 64.33 37.66

Treace Medical Concepts Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 61.24 49.73 37.66 42.31 33.01
TMCI
68GF Score
Treace Medical Concepts Inc TMCI
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Treace Medical Concepts Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of $33.0 Mil mean?
Treace Medical Concepts (TMCI) has a Marketable Securities of $33.0 Mil as of Jun. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Treace Medical Concepts and its competitors.
Is Treace Medical Concepts' Marketable Securities too high?
Treace Medical Concepts' current Marketable Securities is $33.0 Mil. Overall, Treace Medical Concepts has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Treace Medical Concepts' Marketable Securities compare to TLSI and SENS?
Treace Medical Concepts' Marketable Securities of $33.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Treace Medical Concepts and its competitors. Treace Medical Concepts's current Marketable Securities is $33.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Treace Medical Concepts stock overvalued right now?
Based on GuruFocus' analysis, Treace Medical Concepts (TMCI) is currently considered Modestly Undervalued. The stock's GF Value™ is $6.35, compared to a current price of $4.79 — trading 24.6% below its estimated fair value. The current Marketable Securities is $33.0 Mil. Treace Medical Concepts' overall GF Score™ is 68/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Treace Medical Concepts (TMCI), the current Marketable Securities is $33.0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Treace Medical Concepts (TMCI) Overvalued in 2026?

Based on GuruFocus' analysis, Treace Medical Concepts stock appears to be undervalued. The current stock price of $4.79 is trading 24.6% below its estimated GF Value™ of $6.35. GuruFocus considers Treace Medical Concepts to be Modestly Undervalued.

Key valuation signals for TMCI:

  • Marketable Securities: $33.0 Mil
  • GF Value™: $6.35 vs. price of $4.79 (24.6% below fair value)
  • GF Score™: 68/100 with 6 warning signs

No single metric tells the full story. See the TMCI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Treace Medical Concepts Business Description

Address 100 Palmetto Park Place, Ponte Vedra, FL, USA, 32081
Treace Medical Concepts Inc is a commercial-stage orthopaedic medical device company. It is focused on advancing the standard of care for the surgical management of bunion deformities. The company's patented Lapiplasty 3D Bunion Correction procedure is designed to reproducibly correct all planes of the bunion deformity and address the root cause of the bunion, while allowing patients to return to their active lives quickly. The company operates and manages its business as a single segment: designing, manufacturing, and marketing medical devices for surgeons, ambulatory surgery centers, and hospitals related to the surgical management of bunion and related midfoot deformities.
68GF Score

Get the complete analysis for TMCI

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$4.79
Price
$6.35
GF Value